CD28: A Potential Drug Target for Cancer and Other Diseases (G55297)

Target Name: CCDC91

NCBI ID: G55297

CCDC91

CD28: A Potential Drug Target for Cancer and Other Diseases

CCDC91 (DKFZp779L1558), also known as CD28, is a protein that is expressed in various tissues throughout the body, including the immune system, and is involved in cell adhesion, migration, and survival. It has also been shown to play a role in the development and progression of various diseases, including cancer.

Recent studies have identified CCDC91 as a potential drug target for the treatment of various diseases, including cancer. One of the main reasons for its potential as a drug target is its involvement in the development of cancer stem cells, which are a highly aggressive form of cells that can evade the immune system and continue to divide and proliferate even in the presence of treatments.

In addition to its role in cancer development, CCDC91 has also been shown to contribute to the development of other diseases, including autoimmune disorders and neurodegenerative diseases. This makes it an attractive target for researchers to investigate with the goal of developing new treatments for these conditions.

One of the key challenges in studying CCDC91 as a drug target is its complex structure and the various ways in which it can interact with other proteins. Despite its potential as a drug target, much work remains to be done in order to fully understand its role in these diseases and to develop effective treatments.

In conclusion, CCDC91 is a protein that has the potential to be a drug target for the treatment of various diseases, including cancer. Its complex structure and involvement in the development of cancer stem cells make it an attractive target for researchers to investigate, and further studies are needed to fully understand its role in these diseases and to develop effective treatments.

Protein Name: Coiled-coil Domain Containing 91

Functions: Involved in the regulation of membrane traffic through the trans-Golgi network (TGN). Functions in close cooperation with the GGAs in the sorting of hydrolases to lysosomes

The "CCDC91 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC91 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets